Diagnostic value of transferrin

被引:40
作者
Szoke, Dominika
Panteghini, Mauro
机构
[1] Univ Milan, Dipartimento Sci Clin Luigi Sacco, Cattedra Biochim Clin, Milan, Italy
[2] Univ Milan, Dipartimento Sci Clin Luigi Sacco, Biol Mol Clin, Milan, Italy
关键词
Transferrin; Iron deficiency; Iron overload; Risk marker; CLINICAL-PRACTICE GUIDELINES; HEREDITARY HEMOCHROMATOSIS; IRON-DEFICIENCY; SERUM FERRITIN; SATURATION LEVELS; AMERICAN-COLLEGE; POPULATION; MANAGEMENT; OVERLOAD; HFE;
D O I
10.1016/j.cca.2012.04.021
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Despite the growing interest in hepcidin and other relatively new biomarkers, guidelines and clinical pathways continue to recommend traditional markers, such as serum transferrin (Tf) and ferritin, as laboratory tests for the diagnostic evaluation of iron-related disorders. In this study, we aimed to critically evaluate the diagnostic role of Tf relying on the highest level of available evidence by a comprehensive literature search. The role of Tf in iron deficiency (ID) and iron overload (IO) syndrome as well as a risk marker was evaluated. The low accuracy of Tf and Tf saturation (TS) in the diagnosis and management of ID conditions does not permit definitively recommending their use, even if recently published guidelines still consider the TS investigation as a complementary test for ferritin. If a tissue IO is suspected, TS is often used, even if it may not be the best test for detecting this condition. Nevertheless, clinical guidelines strongly recommend the use of TS as a first-level test for performing genetic diagnosis of hereditary hemochromatosis. Recently reported data indicating elevated TS as a risk factor for diabetes mellitus, cancer, and total mortality, may provide useful additions to the debate over whether or not to screen for IO using TS. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:1184 / 1189
页数:6
相关论文
共 54 条
[1]   Hemochromatosis and iron-overload screening in a racially diverse population [J].
Adams, PC ;
Reboussin, DM ;
Barton, JC ;
McLaren, CE ;
Eckfeldt, JH ;
McLaren, GD ;
Dawkins, FW ;
Acton, RT ;
Harris, EL ;
Gordeuk, VR ;
Leiendecker-Foster, C ;
Speechley, M ;
Snively, BM ;
Holup, JL ;
Thomson, E ;
Sholinsky, P ;
Acton, RT ;
Barton, JC ;
Dixon, D ;
Rivers, CA ;
Tucker, D ;
Ware, JC ;
McLaren, CE ;
McLaren, GD ;
Anton-Culver, H ;
Baca, JA ;
Bent, TC ;
Brunner, LC ;
Dao, MM ;
Jorgensen, KS ;
Kuniyoshi, J ;
Le, HD ;
Masatsugu, MK ;
Meyskens, FL ;
Morohashi, D ;
Nguyen, HP ;
Panagon, SN ;
Phung, C ;
Raymundo, V ;
Ton, T ;
Walker, AP ;
Wenzel, LB ;
Ziogas, A ;
Adams, PC ;
Bloch, E ;
Chakrabarti, S ;
Fleischhauer, A ;
Harrison, H ;
Jia, K ;
Larson, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1769-1778
[2]  
Agency for Healthcare Research and Quality, EV BAS PRACT CTR SYS
[3]   Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases [J].
Bacon, Bruce R. ;
Adams, Paul C. ;
Kowdley, Kris V. ;
Powell, Lawrie W. ;
Tavill, Anthony S. .
HEPATOLOGY, 2011, 54 (01) :328-343
[4]   Dealing with iron: Common structural principles in proteins that transport iron and heme [J].
Baker, HM ;
Anderson, BF ;
Baker, EN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3579-3583
[5]  
Besarab A, 2000, J AM SOC NEPHROL, V11, P530, DOI 10.1681/ASN.V113530
[6]   Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA [J].
Beutler, E ;
Felitti, VJ ;
Koziol, JA ;
Ho, NJ ;
Gelbart, T .
LANCET, 2002, 359 (9302) :211-218
[7]  
Beutler Ernest, 2003, Hematology Am Soc Hematol Educ Program, P40
[8]  
British Columbia Medical Association Advisory Committee, GUID PROT IR DEF INV
[9]   Diagnosis and management of iron-deficiency anaemia [J].
Cook, JD .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (02) :319-332
[10]   Coronary heart disease and iron status - Meta-analyses of prospective studies [J].
Danesh, J ;
Appleby, P .
CIRCULATION, 1999, 99 (07) :852-854